Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run

After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...